Shirodkar M, Jabbour SA. Endocrine incidentalomas. Int J Clin Pract 2008;62:1423–31.
CAS
Article
PubMed
Google Scholar
Molitch ME, Russell EJ. The pituitary “incidentaloma”. Ann Intern Med 1990;112:925–31.
CAS
PubMed
Google Scholar
Molitch ME. Pituitary tumours: pituitary incidentalomas. Best Pract Res Clin Endocrinol Metab 2009;23:667–75.
CAS
Article
PubMed
Google Scholar
Chidiac RM, Aron DC. Incidentalomas. A disease of modern technology. Endocrinol Metab Clin North Am 1997;26:233–53.
CAS
Article
PubMed
Google Scholar
Campeau RJ, David O, Dowling AM. Pituitary adenoma detected on FDG positron emission tomography in a patient with mucosa-associated lymphoid tissue lymphoma. Clin Nucl Med 2003;28:296–8.
Article
PubMed
Google Scholar
Bergström M, Muhr C, Lundberg PO, Långström B. PET as a tool in the clinical evaluation of pituitary adenomas. J Nucl Med 1991;32:610–5.
PubMed
Google Scholar
Alzahrani AS, Farhat R, Al-Arifi A, Al-Kahtani N, Kanaan I, Abouzied M. The diagnostic value of fused positron emission tomography/computed tomography in the localization of adrenocorticotropin-secreting pituitary adenoma in Cushing’s disease. Pituitary 2009;12(4):309–14.
CAS
Article
PubMed
Google Scholar
De Souza B, Brunetti A, Fulham MJ, Brooks RA, DeMichele D, Cook P, et al. Pituitary microadenomas: a PET study. Radiology 1990;177:39–44.
PubMed
Google Scholar
Koo CW, Bhargava P, Rajagopalan V, Ghesani M, Sims-Childs H, Kagetsu NJ. Incidental detection of clinically occult pituitary adenoma on whole-body FDG PET imaging. Clin Nucl Med 2006;31:42–3.
Article
PubMed
Google Scholar
Soussan M, Wartski M, Ezra J, Glaisner S, Pecking AP, Alberini JL. Non-Hodgkin lymphoma localization in the pituitary gland: diagnosis by FDG-PET/CT. Clin Nucl Med 2008;33:111–2.
Article
PubMed
Google Scholar
Kluetz PG, Meltzer CC, Villemagne VL, Kinahan PE, Chander S, Martinelli MA, et al. Combined PET/CT imaging in oncology. Impact on patient management. Clin Positron Imaging 2000;3:223–30.
Article
PubMed
Google Scholar
Israel O, Mor M, Guralnik L, Hermoni N, Gaitini D, Bar-Shalom R, et al. Is 18F-FDG PET/CT useful for imaging and management of patients with suspected occult recurrence of cancer? J Nucl Med 2004;45:2045–51.
PubMed
Google Scholar
Bohuslavizki KH, Klutmann S, Kröger S, Sonnemann U, Buchert R, Werner JA, et al. FDG PET detection of unknown primary tumors. J Nucl Med 2000;41:816–22.
CAS
PubMed
Google Scholar
Agress H, Cooper BZ. Detection of clinically unexpected malignant and premalignant tumors with whole-body FDG PET: histopathologic comparison. Radiology 2004;230:417–22.
Article
PubMed
Google Scholar
Jana S, Zhang T, Milstein DM, Isasi CR, Blaufox MD. FDG-PET and CT characterization of adrenal lesions in cancer patients. Eur J Nucl Med Mol Imaging 2006;33:29–35.
Article
PubMed
Google Scholar
Karantanis D, Bogsrud TV, Wiseman GA, Mullan BP, Subramaniam RM, Nathan MA, et al. Clinical significance of diffusely increased 18F-FDG uptake in the thyroid gland. J Nucl Med 2007;48:896–901.
CAS
Article
PubMed
Google Scholar
Chen W, Parsons M, Torigian DA, Zhuang H, Alavi A. Evaluation of thyroid FDG uptake incidentally identified on FDG-PET/CT imaging. Nucl Med Commun 2009;30:240–4.
CAS
Article
PubMed
Google Scholar
Bae JS, Chae BJ, Park WC, Kim JS, Kim SH, Jung SS, et al. Incidental thyroid lesions detected by FDG-PET/CT: prevalence and risk of thyroid cancer. World J Surg Oncol 2009;7:63.
Article
PubMed
Google Scholar
Parent AD, Bebin J, Smith RR. Incidental pituitary adenomas. J Neurosurg 1981;54:228–31.
CAS
Article
PubMed
Google Scholar
Kurosaki M, Saeger W, Lüdecke DK. Pituitary tumors in the elderly. Pathol Res Pract 2001;197:493–7.
CAS
Article
PubMed
Google Scholar
Buurman H, Saeger W. Subclinical adenomas in postmortem pituitaries: classification and correlations to clinical data. Eur J Endocrinol 2006;154:753–8.
CAS
Article
PubMed
Google Scholar
Gambhir SS, Czernin J, Schwimmer J, Silverman DH, Coleman RE, Phelps ME. A tabulated summary of the FDG PET literature. J Nucl Med 2001;42:1S–93.
CAS
PubMed
Google Scholar
Pacak K, Ilias I, Chen CC, Carrasquillo JA, Whatley M, Nieman LK. The role of [(18)F]fluorodeoxyglucose positron emission tomography and [(111)In]-diethylenetriaminepentaacetate-D-Phe-pentetreotide scintigraphy in the localization of ectopic adrenocorticotropin-secreting tumors causing Cushing’s syndrome. J Clin Endocrinol Metab 2004;89:2214–21.
CAS
Article
PubMed
Google Scholar
Kumar J, Spring M, Carroll PV, Barrington SF, Powrie JK. 18Flurodeoxyglucose positron emission tomography in the localization of ectopic ACTH-secreting neuroendocrine tumours. Clin Endocrinol (Oxf) 2006;64:371–4.
CAS
Google Scholar
Sasajima T, Mineura K, Kowada M, Shishido F, Uemura K. Positron emission tomography (PET) of an invasive ACTH-producing pituitary adenoma. Rinsho Hoshasen 1990;35:407–10. Japanese.
CAS
PubMed
Google Scholar
Komori T, Martin WH, Graber AL, Delbeke D. Serendipitous detection of Cushing’s disease by FDG positron emission tomography and a review of the literature. Clin Nucl Med 2002;27:176–8.
Article
PubMed
Google Scholar
Francavilla TL, Miletich RS, DeMichele D, Patronas NJ, Oldfield EH, Weintraub BD, et al. Positron emission tomography of pituitary macroadenomas: hormone production and effects of therapies. Neurosurgery 1991;28:826–33.
CAS
Article
PubMed
Google Scholar
Bonneville JF, Cattin F, Gorczyca W, Hardy J. Pituitary microadenomas: early enhancement with dynamic CT—implications of arterial blood supply and potential importance. Radiology 1993;187:857–61.
CAS
PubMed
Google Scholar
Bonneville JF, Bonneville F, Cattin F. Magnetic resonance imaging of pituitary adenomas. Eur Radiol 2005;15:543–8.
Article
PubMed
Google Scholar